Clathrin mediated endocytosis in Alzheimer’s disease: cell type specific involvement in amyloid beta pathology

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Neurotoxic reactive astrocytes are induced by activated microglia

Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971 · see citing works

Engineering precision nanoparticles for drug delivery

Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933 · see citing works

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · see citing works

The amyloid hypothesis of Alzheimer's disease at 25 years

Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · see citing works

Astrocytes: Biology and pathology

Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · see citing works

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles

Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · see citing works

Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · see citing works

The neuropathological diagnosis of Alzheimer's disease

DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329 · cited 1× · see citing works

2023 Alzheimer's disease facts and figures

(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212 · see citing works

Mechanisms of endocytosis

Doherty, G. J., & McMahon, H. T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.081307.110540 · Cited by 3,075 · see citing works

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059 · see citing works

Amyloid deposition as the central event in the aetiology of Alzheimer’s disease

Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · see citing works

Molecular mechanism and physiological functions of clathrin-mediated endocytosis

McMahon, H. T., & Boucrot, E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3151 · Cited by 2,223 · see citing works

Intracellular amyloid-β in Alzheimer's disease

LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942 · see citing works

Donanemab in Early Alzheimer’s Disease

Mintun, M. A., Lo, A. C., Duggan Evans, C., Wessels, A. M., Ardayfio, P. A., Andersen, S. W., Shcherbinin, S., Sparks, J., Sims, J. R., Brys, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100708 · Cited by 1,728 · cited 1× · see citing works

Mechanisms of clathrin-mediated endocytosis

Kaksonen, M., & Roux, A. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.132 · Cited by 1,698 · see citing works

The role of apolipoprotein E in Alzheimer's disease

Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · see citing works

Regulation of NMDA receptor trafficking by amyloid-β

Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · see citing works

Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics

Rennick, J. J., Johnston, A. P. R., & Parton, R. G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00858-8 · Cited by 1,500 · see citing works

Mechanisms of action of hydroxychloroquine and chloroquine:implications for rheumatology

Schrezenmeier, E., & Dörner, T. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0372-x · Cited by 1,468 · see citing works

The Rotterdam Study: objectives and design update

Albert Hofman, D., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A. P., Stricker, B. H. C., Tiemeier, H. W., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9199-x · Cited by 1,404 · see citing works

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

Budd Haeberlein, S., Aisen, P. S., Barkhof, F., Chalkias, S., Chen, T., Cohen, S., Dent, G., Hansson, O., Harrison, K., von Hehn, C., et al. (2022) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2022.30 · Cited by 1,367 · see citing works

Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020–2060)

Rajan, K. B., Weuve, J., Barnes, L. L., McAninch, E. A., Wilson, R. S., & Evans, D. A. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12362 · Cited by 1,268 · see citing works

Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo

Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265 · see citing works

Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253 · see citing works

APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types

Lin, Y.-T., Seo, J., Gao, F., Feldman, H. M., Wen, H.-L., Penney, J., Cam, H. P., Gjoneska, E., Raja, W. K., Cheng, J., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.008 · Cited by 1,125 · see citing works

Targeting Strategies for Tissue-Specific Drug Delivery

Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,114 · see citing works

Intraneuronal Aβ42 Accumulation in Human Brain

Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991 · see citing works

Evidence that production and release of amyloid beta-protein involves the endocytic pathway

Koo, E. H., & Squazzo, S. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32449-3 · Cited by 989 · see citing works

APP processing in Alzheimer’s disease.

Zhang, Y.-W., Thompson, R., Zhang, H., & Xu, H. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-3 · Cited by 983 · see citing works

Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis.

Stenmark, H., Parton, R. G., Steele‐Mortimer, O., Lütcke, A., Gruenberg, J., & Zerial, M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06381.x · Cited by 968 · see citing works

Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers

Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954 · see citing works

Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds

Holmes, B. B., DeVos, S. L., Kfoury, N., Li, M., Jacks, R., Yanamandra, K., Ouidja, M. O., Brodsky, F. M., Marasa, J., Bagchi, D. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301440110 · Cited by 859 · see citing works

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

Swanson, C. J., Zhang, Y., Dhadda, S., Wang, J., Kaplow, J., Lai, R. Y. K., Lannfelt, L., Bradley, H., Rabe, M., Koyama, A., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00813-8 · Cited by 847 · see citing works

Regulation of synaptic connectivity by glia.

Eroglu, C., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09612 · Cited by 813 · see citing works

Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

Cataldo, A., Peterhoff, C., Troncoso, J., Gómez-Isla, T., Hyman, B., & Nixon, R. (2000) · American Journal of Pathology · doi:10.1016/s0002-9440(10)64538-5 · Cited by 789 · see citing works

Astrocyte Reactivity: Subtypes, States, and Functions in CNS Innate Immunity

Sofroniew, M. V. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.07.004 · Cited by 721 · see citing works

Regulation of AMPA Receptor–Mediated Synaptic Transmission by Clathrin-Dependent Receptor Internalization

Man, H., Lin, J., Ju, W. H., Ahmadian, G., Liu, L., Becker, L. E., Sheng, M., & Wang, Y. T. (2000) · Neuron · doi:10.1016/s0896-6273(00)81067-3 · Cited by 698 · see citing works

Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo

Cirrito, J. R., Kang, J.-E., Lee, J., Stewart, F. R., Verges, D. K., Silverio, L. M., Bu, G., Mennerick, S., & Holtzman, D. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.003 · Cited by 635 · see citing works

To degrade or not to degrade: Mechanisms and significance of endocytic recycling

Cullen, P. J., & Steinberg, F. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0053-7 · Cited by 590 · see citing works

Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease

Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583 · see citing works

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides

Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571 · see citing works

Actin dynamics counteract membrane tension during clathrin-mediated endocytosis

Boulant, S., Kural, C., Zeeh, J., Ubelmann, F., & Kirchhausen, T. L. (2011) · Nature Cell Biology · doi:10.1038/ncb2307 · Cited by 547 · see citing works

Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons

Wu, J. W., Herman, M., Liu, L., Simoes, S., Acker, C. M., Figueroa, H., Steinberg, J. I., Margittai, M., Kayed, R., Zurzolo, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394528 · Cited by 537 · see citing works

Clathrin-independent pathways of endocytosis

Mayor, S., Parton, R. G., & Donaldson, J. G. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016758 · Cited by 525 · see citing works

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation

Chen, Y., & Yu, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02853-3 · Cited by 516 · cited 1× · see citing works

LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease

Heckmann, B. L., Teubner, B. J. W., Tummers, B., Boada-Romero, E., Harris, L., Yang, M., Guy, C. S., Zakharenko, S. S., & Green, D. R. (2019) · Cell · doi:10.1016/j.cell.2019.05.056 · Cited by 503 · see citing works

Astrocytes and microglia: In sickness and in health

Vainchtein, I. D., & Molofsky, A. V. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.01.003 · Cited by 450 · see citing works

Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer’s disease susceptibility

Raj, T., Li, Y. I., Wong, G., Humphrey, J., Wang, M., Ramdhani, S., Wang, Y.-C., Ng, B., Gupta, I., Haroutunian, V., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0238-1 · Cited by 430 · see citing works

Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology

GERAD consortium, Chapuis, J., Hansmannel, F., Gistelinck, M., Mounier, A., Van Cauwenberghe, C., Kolen, K. V., Geller, F., Sottejeau, Y., Harold, D., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.1 · Cited by 407 · see citing works

Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease

Nixon, R. A. (2017) · The FASEB Journal · doi:10.1096/fj.201700359 · Cited by 400 · cited 2× · see citing works

The Rotterdam Study: 2016 objectives and design update

Albert Hofman, D., Brusselle, G., Murad, S. D., van Duijn, C. M., Franco, O. H., Goedegebure, A., Ikram, M. A., Klaver, C. C. W., Nijsten, T. E. C., Peeters, R. P., et al. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0082-x · Cited by 382 · see citing works

Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome

Cataldo, A. M., Petanceska, S., Terio, N. B., Peterhoff, C. M., Durham, R., Mercken, M., Mehta, P. D., Buxbaum, J., Haroutunian, V., & Nixon, R. A. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.027 · Cited by 363 · see citing works

Alzheimer's disease associated with Down syndrome: a genetic form of dementia

Fortea, J., Zaman, S. H., Hartley, S., Rafii, M. S., Head, E., & Carmona-Iragui, M. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00245-3 · Cited by 357 · see citing works

Neuritic regeneration and synaptic reconstruction induced by withanolide A

Kuboyama, T., Tohda, C., & Komatsu, K. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706122 · Cited by 339 · see citing works

Alzheimer’s Disease: An Updated Overview of Its Genetics

Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodríguez, I., Cadena-Suárez, A. R., Sánchez-Garibay, C., Pozo-Molina, G., Méndez-Catalá, C. F., Cardenas-Aguayo, M.-D.-C., Diaz-Cintra, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043754 · Cited by 336 · see citing works

Microglia Phenotypes in Aging and Neurodegenerative Diseases

Wendimu, M. Y., & Hooks, S. B. (2022) · Cells · doi:10.3390/cells11132091 · Cited by 336 · see citing works

The Endosomal-Lysosomal System of Neurons in Alzheimer's Disease Pathogenesis: A Review

Nixon, R., Cataldo, A., & Mathews, P. (2000) · Neurochemical Research · doi:10.1023/a:1007675508413 · Cited by 332 · see citing works

A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ

Kwart, D., Gregg, A., Scheckel, C., Murphy, E. A., Paquet, D., Duffield, M. D., Fak, J. J., Olsen, O., Darnell, R. B., & Tessier‐Lavigne, M. (2019) · Neuron · doi:10.1016/j.neuron.2019.07.010 · Cited by 317 · see citing works

ApoE Cascade Hypothesis in the pathogenesis of Alzheimer’s disease and related dementias

Martens, Y. A., Zhao, N., Liu, C.-C., Kanekiyo, T., Yang, A. J., Goate, A. M., Holtzman, D. M., & Bu, G. (2022) · Neuron · doi:10.1016/j.neuron.2022.03.004 · Cited by 316 · see citing works

A prospective 20‐year longitudinal follow‐up of dementia in persons with Down syndrome

McCarron, M., McCallion, P., Reilly, E., Dunne, P., Carroll, R., & Mulryan, N. (2017) · Journal of Intellectual Disability Research · doi:10.1111/jir.12390 · Cited by 295 · see citing works

Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons

Söllvander, S., Nikitidou, E., Brolin, R., Söderberg, L., Sehlin, D., Lannfelt, L., & Erlandsson, A. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0098-z · Cited by 267 · see citing works

Loss of Bin1 Promotes the Propagation of Tau Pathology

Calafate, S., Flavin, W., Verstreken, P., & Moechars, D. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.063 · Cited by 265 · see citing works

Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease Progression

Ginsberg, S. D., Alldred, M. J., Counts, S., Cataldo, A. M., Neve, R. L., Jiang, Y., Wuu, J., Chao, M. V., Mufson, E. J., Nixon, R. A., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.030 · Cited by 257 · see citing works

TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading

Martini-Stoica, H., Cole, A. L., Swartzlander, D. B., Chen, F., Wan, Y.-W., Bajaj, L., Bader, D. A., Lee, V. M. Y., Trojanowski, J. Q., Liu, Z., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20172158 · Cited by 253 · see citing works

Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells

Usenovic, M., Niroomand, S., Drolet, R. E., Yao, L., Gaspar, R. C., Hatcher, N. G., Schachter, J., Renger, J. J., & Parmentier-Batteur, S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1523-15.2015 · Cited by 245 · see citing works

NMDA Di-Heteromeric Receptor Populations and Associated Proteins in Rat Hippocampus

Al‐Hallaq, R. A., Conrads, T. P., Veenstra, T. D., & Wenthold, R. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2155-07.2007 · Cited by 244 · see citing works

Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis

Root, J. T., Merino, P., Nuckols, A., Johnson, M. A., & Kukar, T. L. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105360 · Cited by 230 · see citing works

Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study

van Gool, W. A., Weinstein, H. C., Scheltens, P., & Walstra, G. J. M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05623-9 · Cited by 210 · see citing works

Defects in expression of genes related to synaptic vesicle traffickingin frontal cortex of Alzheimer’s disease

Yao, P. J., Zhu, M., Pyun, E. I., Brooks, A. I., Therianos, S., Meyers, V. E., & Coleman, P. D. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00009-8 · Cited by 205 · see citing works

Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease

Al-Ghraiybah, N. F., Wang, J., Alkhalifa, A. E., Roberts, A. B., Raj, R., Yang, E., & Kaddoumi, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810572 · Cited by 204 · see citing works

Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance

Congdon, E. E., Gu, J., Sait, H. B. R., & Sigurdsson, E. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.491001 · Cited by 195 · see citing works

Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways

Evans, L., Wassmer, T., Fraser, G. M., Smith, J. C., Perkinton, M. S., Billinton, A., & Livesey, F. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.021 · Cited by 187 · see citing works

Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer’s Disease

Colacurcio, D. J., Pensalfini, A., Jiang, Y., & Nixon, R. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.001 · Cited by 167 · see citing works

Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99)

Jiang, Y., Sato, Y., Im, E., Berg, M., Bordi, M., Darji, S., Kumar, A., Mohan, P. S., Bandyopadhyay, U., Diaz, A., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0578-19.2019 · Cited by 166 · see citing works

Endosomal Traffic Jams Represent a Pathogenic Hub and Therapeutic Target in Alzheimer’s Disease

Small, S. A., Simoes, S., Mayeux, R. P., & Petsko, G. A. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.08.003 · Cited by 163 · see citing works

Endocytic membrane trafficking and neurodegenerative disease

Schreij, A. M. A., Fon, E. A., & McPherson, P. S. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2105-x · Cited by 153 · see citing works

Alzheimer's disease first symptoms are age dependent: Evidence from the NACC dataset

Barnes, J., Dickerson, B. C., Frost, C. D., Jiskoot, L. C., Wolk, D. A., & van der Flier, W. M. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.12.007 · Cited by 152 · see citing works

Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts

De Rossi, P., Buggia-Prévot, V., Clayton, B. L. L., Vasquez, J. B., van Sanford, C., Andrew, R. J., Lesnick, R., Botté, A., Deyts, C., Salem, S., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0124-1 · Cited by 151 · see citing works

The aging lysosome: An essential catalyst for late-onset neurodegenerative diseases

Nixon, R. A. (2020) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2020.140443 · Cited by 149 · see citing works

NMDA and AMPA receptors dysregulation in Alzheimer's disease

Babaei, P. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174310 · Cited by 149 · see citing works

Clathrin Adaptor AP-2 Is Essential for Early Embryonal Development

Mitsunari, T., Nakatsu, F., Shioda, N., Love, P. E., Grinberg, A., Bonifacino, J. S., & Ohno, H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9318-9323.2005 · Cited by 142 · see citing works

Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer’s brains

Ando, K., Brion, J.-P., Stygelbout, V., Suain, V., Authelet, M., Dedecker, R., Chanut, A., Lacor, P., Lavaur, J., Sazdovitch, V., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1111-z · Cited by 136 · see citing works

Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia

Das, R. R., Balmik, A. A., & Chinnathambi, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1694-y · Cited by 129 · see citing works

Revisiting the Role of Clathrin-Mediated Endoytosis in Synaptic Vesicle Recycling

Milosevic, I. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00027 · Cited by 122 · see citing works

Distribution and Expression of Picalm in Alzheimer Disease

Baig, S., Joseph, S. A., Tayler, H., Abraham, R., Owen, M. J., Williams, J., Kehoe, P. G., & Love, S. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181f52e01 · Cited by 115 · see citing works

Endocytic uptake of monomeric amyloid-β peptides is clathrin- and dynamin-independent and results in selective accumulation of Aβ(1–42) compared to Aβ(1–40)

Wesén, E. V., Jeffries, G. D. M., Dzebo, M. M., & Esbjörner, E. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-02227-9 · Cited by 114 · see citing works

Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer’s disease, progressive supranuclear palsy and dementia with Lewy bodies

Puangmalai, N., Bhatt, N. N., Montalbano, M., Sengupta, U., Gaikwad, S., Ventura, F. L., McAllen, S., Ellsworth, A., García, S., & Kayed, R. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2503-3 · Cited by 110 · see citing works

Spreading of tau pathology in A lzheimer's disease by cell‐to‐cell transmission

Mohamed, N., Herrou, T., Plouffe, V., Piperno, N., & Leclerc, N. M. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12229 · Cited by 110 · see citing works

Oligomer-specific Aβ toxicity in cell models is mediated by selective uptake

Chafekar, S. M., Baas, F., & Scheper, W. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.06.003 · Cited by 110 · see citing works

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity

Jin, S., Kedia, N., Illes‐Toth, E., Haralampiev, I., Prisner, S., Herrmann, A., Wanker, E. E., & Bieschke, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.691840 · Cited by 109 · see citing works

New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease

Zhang, F., Zhong, R.-J., Cheng, C., Li, S., & Le, W.-D. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00565-5 · Cited by 105 · see citing works

PICALM and Alzheimer’s Disease: An Update and Perspectives

Ando, K., Nagaraj, S., Küçükali, F., de Fisenne, M.-A., Kosa, A.-C., Doeraene, E., Lopez Gutierrez, L., Brion, J.-P., & Leroy, K. (2022) · Cells · doi:10.3390/cells11243994 · Cited by 104 · see citing works

Current Status of Clinical Trials on Tau Immunotherapies

Ji, C., & Sigurdsson, E. M. (2021) · Drugs · doi:10.1007/s40265-021-01546-6 · Cited by 96 · see citing works

Modes and mechanisms of synaptic vesicle recycling

Soykan, T., Maritzen, T., & Haucke, V. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.03.005 · Cited by 94 · see citing works

Amyloid‐β impairs the phagocytosis of dystrophic synapses by astrocytes in Alzheimer's disease

Sanchez‐Mico, M. V., Jimenez, S., Gomez‐Arboledas, A., Muñoz‐Castro, C., Romero‐Molina, C., Navarro, V., Sanchez‐Mejias, E., Nuñez‐Diaz, C., Sanchez‐Varo, R., Galea, E., et al. (2021) · Glia · doi:10.1002/glia.23943 · Cited by 93 · see citing works

Clathrin-mediated endocytosis and Alzheimer's disease: An update

Wu, F., & Yao, P. J. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.03.002 · Cited by 92 · see citing works

An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer’s Disease

Ratan, Y., Rajput, A., Maleysm, S., Pareek, A., Jain, V. K., Pareek, A., Kaur, R., & Singh, G. (2023) · Biomedicines · doi:10.3390/biomedicines11051398 · Cited by 87 · see citing works

The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death

Thal, D. R., & Tomé, S. O. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.006 · Cited by 85 · see citing works

Regulation of synaptic vesicle recycling by complex formation between intersectin 1 and the clathrin adaptor complex AP2

Pechstein, A., Bacetic, J., Vahedi‐Faridi, A., Gromova, K. V., Sundborger, A., Tomlin, N., Krainer, G., Vorontsova, O. V., Schäfer, J. G., Owe, S. G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911073107 · Cited by 85 · see citing works

The Role of Microglia in Sporadic Alzheimer’s Disease

Streit, W. J., Khoshbouei, H., & Bechmann, I. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201248 · Cited by 84 · see citing works

The role of Alzheimer's disease risk genes in endolysosomal pathways

Szabo, M. P., Mishra, S., Knupp, A., & Young, J. E. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105576 · Cited by 81 · see citing works

Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease

Rabinovici, G. D., & La Joie, R. (2023) · JAMA · doi:10.1001/jama.2023.11703 · Cited by 80 · see citing works

A closer look at astrocyte morphology: Development, heterogeneity, and plasticity at astrocyte leaflets

Ceja, B. T., & Olsen, M. L. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102550 · Cited by 80 · see citing works

PICALM Rescues Endocytic Defects Caused by the Alzheimer’s Disease Risk Factor APOE4

Narayan, P., Sienski, G., Bonner, J. M., Lin, Y.-T., Seo, J., Baru, V., Haque, A., Milo, B., Akay, L. A., Graziosi, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108224 · Cited by 75 · see citing works

GluA1 subunit ubiquitination mediates amyloid-β-induced loss of surface α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors

Guntupalli, S., Jang, S. E., Zhu, T., Huganir, R. L., Widagdo, J., & Anggono, V. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.774554 · Cited by 70 · see citing works

The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications

Szewczyk-Roszczenko, O. K., Roszczenko, P., Shmakova, A., Finiuk, N. S., Holota, S. M., Lesyk, R., Bielawska, A., Vassetzky, Y. S., & Bielawski, K. (2023) · Cells · doi:10.3390/cells12182312 · Cited by 70 · see citing works

Differences in the Cellular Uptake and Intracellular Itineraries of Amyloid Beta Proteins 40 and 42: Ramifications for the Alzheimer’s Drug Discovery

Omtri, R. S., Davidson, M. W., Arumugam, B., Poduslo, J. F., & Kandimalla, K. K. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200530q · Cited by 68 · see citing works

Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s disease

Tesi, N., van der Lee, S. J., Hulsman, M., Jansen, I. E., Stringa, N., van Schoor, N. M., Scheltens, P., van der Flier, W. M., Huisman, M., Reinders, M. J. T., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01018-7 · Cited by 67 · see citing works

Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease

Kim, S., Cho, Y.-S., Kim, Y., Park, J., Yoo, S., Gwak, J., Kim, Y., Gwon, Y., Kam, T., & Jung, Y. (2023) · Autophagy · doi:10.1080/15548627.2023.2181614 · Cited by 65 · see citing works

Imaging and Modeling the Dynamics of Clathrin-Mediated EndocytosisPreprint

Mettlen, M., & Danuser, G. M. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a017038 · Cited by 61 · see citing works

Misfolded amyloid-β-42 impairs the endosomal–lysosomal pathway

Marshall, K. E., Vadukul, D. M., Staras, K., & Serpell, L. C. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03464-4 · Cited by 59 · see citing works

Upregulation of APP endocytosis by neuronal aging drives amyloid-dependent synapse loss

Burrinha, T., Martinsson, I., Gomes, R. A., Terrasso, A. P., Gouras, G. K., & Almeida, C. G. (2021) · Journal of Cell Science · doi:10.1242/jcs.255752 · Cited by 56 · see citing works

Synaptic frailty and clathrin-mediated synaptic vesicle trafficking in Alzheimer's disease

Yao, P. J. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.10.012 · Cited by 55 · see citing works

Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer’s disease

Thomas, R. S., Henson, A., Gerrish, A., Jones, L., Williams, J., & Kidd, E. J. (2016) · BMC Neuroscience · doi:10.1186/s12868-016-0288-1 · Cited by 55 · see citing works

Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer’s Disease Before 51 Years

Lacour, M., Quenez, O., Rovelet‐Lecrux, A., Salomon, B., Rousseau, S., Richard, A., Quillard‐Muraine, M., Pasquier, F., Rollin‐Sillaire, A., Martinaud, O., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190193 · Cited by 53 · see citing works

Brain clearance of protein aggregates: a close-up on astrocytes

Giusti, V., Kaur, G., Giusto, E., & Civiero, L. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00703-1 · Cited by 52 · see citing works

Hydroxychloroquine lowers Alzheimer’s disease and related dementias risk and rescues molecular phenotypes related to Alzheimer’s disease

Varma, V. R., Desai, R. J., Navakkode, S., Wong, L., Anerillas, C., Loeffler, T., Schilcher, I., Mahesri, M., Chin, K., Horton, D. B., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01912-0 · Cited by 51 · see citing works

Impact of late-onset Alzheimer’s genetic risk factors on beta-amyloid endocytic production

Almeida, C. G., Mirfakhar, F. S., Perdigão, C., & Burrinha, T. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2825-9 · Cited by 48 · see citing works

Changes in synaptic expression of clathrin assembly protein AP180 in Alzheimer's disease analysed by immunohistochemistry

Yao, P. J., Morsch, R., Callahan, L. M., & Coleman, P. D. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00360-7 · Cited by 48 · see citing works

Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease

Zhao, Y., Liu, B., Wang, J., Xu, L., Yu, S., Fu, J., Yan, X., & Su, J. (2022) · Biomedicines · doi:10.3390/biomedicines10081800 · Cited by 47 · see citing works

Tau internalization: A complex step in tau propagation

Zhao, J., Wu, H., & Tang, X. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101272 · Cited by 46 · see citing works

Endocytic Adaptor Proteins in Health and Disease: Lessons from Model Organisms and Human Mutations

Azarnia Tehran, D., López-Hernández, T., & Maritzen, T. (2019) · Cells · doi:10.3390/cells8111345 · Cited by 44 · see citing works

Astrocytic accumulation of tau fibrils isolated from Alzheimer’s disease brains induces inflammation, cell-to-cell propagation and neuronal impairment

Eltom, K., Mothes, T., Libard, S., Ingelsson, M., & Erlandsson, A. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01745-8 · Cited by 44 · see citing works

Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study

Ahmad, S., Bannister, C. A., van der Lee, S. J., Vojinović, D., Adams, H. H. H., Ramı́rez, A., Escott‐Price, V., Sims, R., Baker, E. A., Williams, J. H., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.01.005 · Cited by 44 · see citing works

Proteins Involved in Endocytosis Are Upregulated by Ageing in the Normal Human Brain: Implications for the Development of Alzheimer’s Disease

Alsaqati, M., Thomas, R. S., & Kidd, E. J. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx135 · Cited by 43 · see citing works

Changed Clathrin Regulatory Proteins in the Brains of Alzheimer's Disease Patients and Animal Models

Cao, Y., Xiao, Y. C., Ravid, R., & Guan, Z. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100162 · Cited by 43 · see citing works

Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake

La‐Rocque, S. D., Moretto, E., Butnaru, I., & Schiavo, G. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15144 · Cited by 42 · see citing works

Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer’s Disease

Domínguez-Prieto, M., Velasco, A. L., Tabernero, A., & Medina, J. M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180332 · Cited by 42 · see citing works

Clathrin-mediated endocytic proteins are upregulated in the cortex of the Tg2576 mouse model of Alzheimer’s disease-like amyloid pathology

Thomas, R. S., Lelos, M. J., Good, M. A., & Kidd, E. J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.131 · Cited by 41 · see citing works

Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis

Ando, K., Houben, S., Homa, M., de Fisenne, M.-A., Potier, M., Erneux, C., Brion, J., & Leroy, K. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.583755 · Cited by 39 · see citing works

The Shaping of AMPA Receptor Surface Distribution by Neuronal Activity

Chater, T. E., & Goda, Y. (2022) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2022.833782 · Cited by 37 · see citing works

Traffic jam hypothesis: Relationship between endocytic dysfunction and Alzheimer's disease

Kimura, N., & Yanagisawa, K. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.002 · Cited by 37 · see citing works

Association of AEBP1 and NRN1 RNA expression with Alzheimer’s disease and neurofibrillary tangle density in middle temporal gyrus

Piras, I. S., Krate, J., Delvaux, E., Nolz, J., Both, M. D. D., Mastroeni, D., Serrano, G. E., Sue, L. I., Beach, T. G., Coleman, P. D., et al. (2019) · Brain Research · doi:10.1016/j.brainres.2019.06.004 · Cited by 36 · see citing works

CD14 and Toll-Like Receptor 4 Promote Fibrillar Aβ42 Uptake by Microglia Through A Clathrin-Mediated Pathway

Fujikura, M., Iwahara, N., Hisahara, S., Kawamata, J., Matsumura, A., Yokokawa, K., Saito, T., Manabe, T., Matsushita, T., Suzuki, S., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180904 · Cited by 35 · see citing works

Translational gene mapping of cognitive decline

Wilmot, B., McWeeney, S. K., Nixon, R. R., Montine, T. J., Laut, J., Harrington, C. A., Kaye, J. A., & Kramer, P. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.008 · Cited by 35 · see citing works

Dysfunctional microglia and tau pathology in Alzheimer’s disease

Ayyubova, G. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0087 · Cited by 35 · see citing works

Inhibition of β-amyloid1-42 internalization attenuates neuronal death by stabilizing the endosomal-lysosomal system in rat cortical cultured neurons

Song, M.-S., Baker, G. B., Todd, K. G., & Kar, S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.12.055 · Cited by 34 · see citing works

Microtubule assembly by tau impairs endocytosis and neurotransmission via dynamin sequestration in Alzheimer’s disease synapse model

Hori, T., Eguchi, K., Wang, H.-Y., Miyasaka, T., Guillaud, L., Taoufiq, Z., Mahapatra, S., Yamada, H., Takei, K., & Takahashi, T. (2022) · eLife · doi:10.7554/elife.73542 · Cited by 34 · see citing works

How brain ‘cleaners’ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer's disease

Ni, J., Xie, Z., Quan, Z., Meng, J., & Qing, H. (2023) · Glia · doi:10.1002/glia.24465 · Cited by 33 · see citing works

Amphiphysin-1 protein level changes associated with tau-mediated neurodegeneration

Jesús‐Cortés, H. D., Nogueras‐Ortiz, C. J., Gearing, M., Arnold, S. E., & Vega, I. E. (2012) · Neuroreport · doi:10.1097/wnr.0b013e32835982ce · Cited by 31 · see citing works

Dynamin 2 gene is a novel susceptibility gene for late-onset Alzheimer disease in non-APOE-ε4 carriers

Nuripa, A., Kamino, K., Kimura, R., Yamamoto, M. L., Morihara, T., Kazui, H., Hashimoto, R., Tanaka, T., Kudo, T., Kida, T., et al. (2008) · Journal of Human Genetics · doi:10.1007/s10038-008-0251-9 · Cited by 30 · see citing works

Involvement of clathrin light chains in the pathology of Alzheimer's disease

Nakamura, Y., Takeda, M., Yoshimi, K., Hattori, H., Hariguchi, S., Kitajima, S., Hashimoto, S., & Nishimura, T. (1994) · Acta Neuropathologica · doi:10.1007/bf00386251 · Cited by 30 · see citing works

Selective endocytosis of Ca 2+ -permeable AMPARs by the Alzheimer’s disease risk factor CALM bidirectionally controls synaptic plasticity

Tehran, D. A., Kochlamazashvili, G., Pampaloni, N. P., Sposini, S., Shergill, J. K., Lehmann, M., Pashkova, N., Schmidt, C., Löwe, D., Napieczyńska, H., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl5032 · Cited by 29 · see citing works

Endosomal‐lysosomal dysfunctions in Alzheimer’s disease: Pathogenesis and therapeutic interventions

Lai, S. S. M., Ng, K. Y., Koh, R. Y., Chok, K. C., & Chye, S. M. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00737-0 · Cited by 28 · see citing works

The Role of Synaptic Dysfunction in Alzheimer’s Disease

Pei, Y. A., Davies, J., Zhang, M., & Zhang, H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191334 · Cited by 28 · see citing works

Tau Oligomers in Sera of Patients with Alzheimer’s Disease and Aged Controls

Kolarova, M., Sengupta, U., Bartos, A., Ricny, J., & Kayed, R. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170048 · Cited by 27 · see citing works

Tau overexpression impairs neuronal endocytosis by decreasing the GTPase dynamin 1 through the miR‐132/MeCP2 pathway

Xie, A., Hou, T., Xiong, W., Huang, H., Zheng, J., Li, K., Man, H., Hu, Y., Han, Z., Zhang, H., et al. (2019) · Aging Cell · doi:10.1111/acel.12929 · Cited by 27 · see citing works

Decrease of dynamin 2 levels in late-onset Alzheimer’s disease alters Aβ metabolism

Kamagata, E., Kudo, T., Kimura, R., Tanimukai, H., Morihara, T., Sadik, M. G., Kamino, K., & Takeda, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.147 · Cited by 27 · see citing works

Inhibition of clathrin-mediated endocytosis prevents amyloid β-induced axonal damage

Kuboyama, T., Lee, Y., Nishiko, H., & Tohda, C. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.005 · Cited by 26 · see citing works

An Aβ42 uptake and degradation via Rg3 requires an activation of caveolin, clathrin and Aβ-degrading enzymes in microglia

Jang, S. K., Yu, J. M., Kim, S. T., Kim, G. H., Park, D. W., Lee, D. I., & Joo, S. S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.071 · Cited by 26 · see citing works

Implication of tau propagation on neurodegeneration in Alzheimer’s disease

Lamontagne-Kam, D., Ulfat, A. K., Hervé, V., Vu, T.-M., & Brouillette, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1219299 · Cited by 25 · see citing works

The function of astrocytes and their role in neurological diseases

Yuan, W., Huang, W., Jiang, Y., Xu, H., Duan, C., Chen, N., Liu, Y., & Fu, X. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16160 · Cited by 24 · see citing works

The Amyloid Cascade Hypothesis 2.0: Generalization of the Concept

Volloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220079 · Cited by 21 · see citing works

Molecular Regulation Mechanism of Microglial Autophagy in the Pathology of Alzheimer's Disease

Ou-Yang, P., Cai, Z., & Zhang, Z.-H. (2023) · Aging and Disease · doi:10.14336/ad.2023.0106 · Cited by 21 · see citing works

Cell type-specific functions of Alzheimer's disease endocytic risk genes

Maninger, J., Nowak, K., Goberdhan, S., O’Donoghue, R., & Connor‐Robson, N. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0378 · Cited by 21 · see citing works

Exploring the potential role of rab5 protein in endo-lysosomal impairment in Alzheimer’s disease

Behl, T., Kaur, D., Sehgal, A., Singh, S., Makeen, H. A., Albratty, M., Abdellatif, A. A. H., Dachani, S. R., & BUNGAU, S. G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112773 · Cited by 20 · see citing works

Endosome Dysregulation in Down Syndrome: A Potential Contributor to Alzheimer Disease Pathology

Filippone, A., & Praticò, D. (2021) · Annals of Neurology · doi:10.1002/ana.26042 · Cited by 20 · see citing works

Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndrome.

Botté, A., & Potier, M. (2020) · Progress in Brain Research · doi:10.1016/bs.pbr.2019.10.002 · Cited by 20 · see citing works

Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer’s Disease-Related Biomarkers

Schork, N. J., Elman, J. A., & Initiative, A. D. N. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230548 · Cited by 20 · see citing works

Endocytosis Is a Key Mode of Interaction between Extracellular β-Amyloid and the Cell Membrane

Shi, J., Zhu, L., Lan, X., Zhao, D.-W., He, Y., Sun, Z.-Q., Wu, D., & Li, H. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.07.035 · Cited by 19 · see citing works

Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice

Zhang, X., Zou, L., Tang, L., Xiong, M., Yan, X., Meng, L., Chen, G., Xiong, J., Nie, S., Zhang, Z., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002470 · Cited by 19 · see citing works

Astrocytes Derived from Familial and Sporadic Alzheimer’s Disease iPSCs Show Altered Calcium Signaling and Respond Differently to Misfolded Protein Tau

Brezováková, V., Syková, E., & Jadhav, S. (2022) · Cells · doi:10.3390/cells11091429 · Cited by 18 · see citing works

Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice

Cuddy, L. K., Alia, A. O., Salvo, M. A., Chandra, S., Grammatopoulos, T. N., Justman, C. J., Lansbury, P. T., Mazzulli, J. R., & Vassar, R. J. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00561-9 · Cited by 17 · see citing works

Clathrin assembly protein AP-2 is detected in both neurons and glia, and its reduction is prominent in layer II of frontal cortex in Alzheimer's disease

Yao, P. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00228-1 · Cited by 17 · see citing works

Endosomal trafficking and related genetic underpinnings as a hub in Alzheimer's disease

Limone, A., Veneruso, I., D’Argenio, V., & Sarnataro, D. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30864 · Cited by 16 · see citing works

Recent Trends in Active and Passive Immunotherapies of Alzheimer’s Disease

Alshamrani, M. (2023) · Antibodies · doi:10.3390/antib12020041 · Cited by 16 · see citing works

Alpha adaptins show isoform‐specific association with neurofibrillary tangles in Alzheimer's disease

Srinivasan, S., Gál, J., Bachstetter, A. D., & Nelson, P. T. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12776 · Cited by 15 · see citing works

The Amyloid Cascade Hypothesis 2.0: On the Possibility of Once-in-a-Lifetime-Only Treatment for Prevention of Alzheimer’s Disease and for Its Potential Cure at Symptomatic Stages

Volloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220031 · Cited by 14 · see citing works

Beyond the classical amyloid hypothesis in Alzheimer's disease: Molecular insights into current concepts of pathogenesis, therapeutic targets, and study models

Theerasri, A., Janpaijit, S., Tencomnao, T., & Prasansuklab, A. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1591 · Cited by 13 · see citing works

Dynein dysfunction disrupts β-amyloid clearance in astrocytes through endocytic disturbances

Kimura, N., Okabayashi, S., & Ono, F. (2014) · Neuroreport · doi:10.1097/wnr.0000000000000124 · Cited by 13 · see citing works

Upregulation of endocytic protein expression in the Alzheimer’s disease male human brain

Alsaqati, M., Thomas, R. S., & Kidd, E. J. (2023) · Aging Brain · doi:10.1016/j.nbas.2023.100084 · Cited by 10 · see citing works

Role of Membrane Tension Sensitive Endocytosis and Rho GTPases in the Uptake of the Alzheimer’s Disease Peptide Aβ(1-42)

Wesén, E. V., Lundmark, R., & Esbjörner, E. K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00053 · Cited by 9 · see citing works

The Down Syndrome-Associated Protein, Regulator of Calcineurin-1, is Altered in Alzheimer's Disease and Dementia with Lewy Bodies.

Malakooti, N., Fowler, C., Volitakis, I., Ca, M., Rc, K., Ai, B., Rembach, A., Ma, P., Finkelstein, D. I., & Pa, A. (2019) · PubMed · doi:10.4172/2161-0460.1000462 · Cited by 9 · see citing works

The Oligomeric Form of Amyloid Beta Triggers Astrocyte Activation, Independent of Neurons

Mun, B.-R., Park, S.-B., & Choi, W. (2024) · Chonnam Medical Journal · doi:10.4068/cmj.2024.60.1.27 · Cited by 5 · see citing works

TargetCLP: clathrin proteins prediction combining transformed and evolutionary scale modeling-based multi-view features via weighted feature integration approach

Ullah, M., Akbar, S., Raza, A., Khan, K. A., & Zou, Q. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf026 · Cited by 48 · see citing works

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Kadamangudi, S., Marcatti, M., Zhang, W.-R., Fracassi, A., Kayed, R., Limon, A., & Taglialatela, G. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02839-2 · Cited by 25 · see citing works

Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer’s disease

Jury-Garfe, N., Redding-Ochoa, J., You, Y., Martínez, P., Karahan, H., Chimal-Juárez, E., Johnson, T. S., Zhang, J., Resnick, S., Kim, J., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02775-1 · Cited by 22 · see citing works

Microglial Dysfunction and Amyloid-Beta Pathology in Alzheimer’s Disease and HIV-Associated Neurocognitive Disorders

Njoku, G. C., & Kanmogne, G. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189069 · Cited by 15 · see citing works

Membrane-associated periodic skeleton regulates major forms of endocytosis in neurons through a signaling-driven positive feedback loop

Fei, J., Zheng, Y., LaLonde, C., Tao, Y., & Zhou, R. (2026) · Science Advances · doi:10.1126/sciadv.aeb0803 · Cited by 8 · see citing works

The circadian clock regulates scavenging of fluid-borne substrates by brain border-associated macrophagesPreprint

Barr, H. J., Caldwell, S. K., Reimertz, J. M., Depp, C., Walker, A. J., Marsh, S. E., Gupte, A. S., Hingerl, M., Patel, J., Park, S.-O., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.08.693074 · Cited by 8 · see citing works

A clathrin mediated endocytosis scaffolding protein, Intersectin 1, changes in an isoform, brain region, and sex specific manner in Alzheimer’s disease

Jaye, S., Sandau, U. S., McFarland, T. J., Woltjer, R. L., & Saugstad, J. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1426180 · Cited by 5 · see citing works

Neurodegenerative diseases reflect the reciprocal roles played by retroelements in regulating memory and immunity

Herbert, A. G. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1445540 · Cited by 5 · see citing works

Endocytic Pathways Unveil the Role of Syndecans in the Seeding and Spreading of Pathological Protein Aggregates: Insights into Neurodegenerative Disorders

Hudák, A., & Letoha, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094037 · Cited by 5 · see citing works

KGiA: Drug repurposing through disease-aware knowledge graph augmentation

Oğuztüzün, Ç., Gao, Z., Li, H., & Xu, R. (2025) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2025.104857 · Cited by 4 · see citing works

Is the Voltage-Dependent Anion Channel a Major Player in Neurodegenerative Diseases?

Neumann, S., & Heumann, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136138 · Cited by 4 · see citing works

Clathrin-mediated endocytosis in budding yeast at a glance: animated

Owen, L. M., Riggi, M., Drubin, D. G., Iwasa, J., & Sun, Y. (2025) · Journal of Cell Science · doi:10.1242/jcs.264222 · Cited by 2 · see citing works

Insulin-like growth factor-1 enhances β-amyloid protein clearance in HMC3 microglia via low-density lipoprotein receptor-related protein 1-mediated pathway

Guo, H., Peng, X., Zhang, X. C., Ruganzu, J. B., Wu, X., Zhao, M., Pengbo, Y., Ji, S., & Yang, W. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114920 · Cited by 1 · see citing works

Traumatic Brain Injury and Endocytosis: Reduced Rodent Hippocampal Endocytosis Proteins and Human Clathrin Light Chain Polymorphisms Are Associated with Impaired Neurological Outcomes After TBI

Svirsky, S. E., Roberts, A., Parry, M., Henchir, J. J., Dixon, C. E., Jackson, T. C., Chang, Y., Conley, Y., Puccio, A. M., & Carlson, S. W. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05709-y · Cited by 1 · see citing works

Single-cell, multi-region profiling of the macaque brain across the lifespanPreprint

Yang, W., Watkins, K., DeCasien, A. R., O’Neill, M. B., Bohlen, M. O., O’Day, D. R., Duran, M., Qiu, C., Meleshko, A. N., Vo, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.31.685880 · Cited by 1 · see citing works

The Flipons, Infections, and Amyloids that Foreshadow the Fading Memories of Alzheimer’s Disease

Herbert, A. G. (2025) · Neuroscience Insights · doi:10.1177/26331055251338815

PICALM Genetic Variant Alters mRNA Expression Without Affecting Protein Levels or Tau Spreading in Alzheimer’s Disease

Ando, K., Lopez‐Gutierrez, L., Mansour, S., Yilmaz, Z., Dauphinot, L., Verheijen, J., Fontaine, G., Quintanilla‐Sánchez, C., Aydin, E., Doeraene, E., et al. (2026) · Cells · doi:10.3390/cells15030235

Endocytic Adaptor Proteins in Vascular Diseases: Critical Role of Intracellular Trafficking in Regulating Pathobiology of Vascular Disorders

Gao, J., Zhu, B. J., Wang, B., Singh, B., Eisa-Beygi, S., Wu, H., Cui, K., Kulandaisamy, A., Huang, W., Wei, W., et al. (2026) · Cardiology Discovery · doi:10.1097/cd9.0000000000000188

BAG3 modulates clathrin-mediated endocytosis and tau uptake in astrocytes

Rodwell‐Bullock, J., Blau, E., Ganguly, A., Deaton, C. A., & Johnson, G. V. W. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00947.2025

Self-Assembling Short Peptide Carriers for Gene Delivery

An, L., Xu, Z., & Zhang, X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083464

Proximity labeling reveals unique and shared proximal proteomes associated with pE3-Aβ and 6E10 amyloid pathology in human Alzheimer’s disease hippocampus

Alia, A. O., Urquhart, K., Carson, H., Killinger, B. A., Janson, C., & Romanova, L. Y. (2026) · Acta Neuropathologica Communications · doi:10.64898/2026.05.13.724866

Chemokine receptor CX3CR1 interacts with Tau and regulates its microglial activity in Alzheimer’s disease

Chinnathambi, S., Baisya, U., & Ananthanarayana, V. (2026) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2026.07.004

3D nanoscale imaging of amyloid-β oligomer interactions with extracellular vesicles by cryo-ET

Khursheed, A., Shang, Q., Zhang, H., Tian, Y., Szwedziak, P., Volkov, V. A., & Viles, J. H. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2610068123

Association of cerebrospinal fluid amphiphysin-1 levels with cognition and Alzheimer’s disease pathology biomarkers

Fan, J.-D., Fu, Y., Li, Q., Zhang, Z.-Q., Zhao, Y., Hao, Q., Tan, L., Tan, M., & Initiative, T. A. D. N. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1875646

From Pits to Plaques: Electron Microscopy Reveals Clathrin Structural Plasticity in Trafficking, Sorting and Adhesion

Benoist, M., & Vassilopoulos, S. (2026) · Traffic · doi:10.1111/tra.70053

Stage-specific proteomic signatures of synaptopathy in Alzheimer’s diseasePreprint

Georgiades, T., Griffiths, J., Gibbs, F., Chandra, E. A., Papageorgopoulou, M., Liang, D., Whitwell, H. J., Matthews, P. M., Barnes, S. J., Grant, S. G. N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.02.755976

Engineered hUC-MSC exosomes loaded with pterostilbene induce Nrf2/SKN-1-dependent microglial M2 polarization and neuroprotection in Alzheimer's disease in vitro and in Caenorhabditis elegans

Zhang, Y., Su, Y., Huang, L., Guan, H., Qiu, Z., & Zou, C. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117575

Clathrin Mediated Endocytosis in Alzheimer’s Disease: Using Biomarkers to Uncover Disease Mechanism

Smith, S. J. (2023) · OHSU Digital Commons · doi:10.6083/bpxhc42886

Clathrin-mediated endocytosis and Alzheimer's disease: An update

Wu, F., & Yao, P. J. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.03.002 · Cited by 92 · see citing works

Endocytosis and Alzheimer’s disease

Zadka, Ł., Sochocka, M., Hachiya, N., Chojdak-Łukasiewicz, J., Dzięgiel, P., Piasecki, E., & Leszek, J. (2023) · GeroScience · doi:10.1007/s11357-023-00923-1 · Cited by 32 · see citing works

Endocytosis in β-amyloid biology and Alzheimer’s disease

Heckmann, B. L., & Green, D. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89906-2.00009-5

Autophagy and Alzheimer’s Disease: Mechanisms and Impact Beyond the Brain

Hein, Z. M., Vishnumukkala, T., Karikalan, B., Alkatiri, A., Hussan, F., Jagadeesan, S., Kamaruzzaman, M. A., Ramli, M. D. C., Nassir, C. M. N. C. M., & Gopalakrishna, P. K. (2025) · Cells · doi:10.3390/cells14120911 · Cited by 36 · see citing works